DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: TREATMENTS
       *****************************************************
       #Post#: 4316--------------------------------------------------
       (NEJM) Inhibition of CD40L with frexalimab in MS
       By: agate Date: February 15, 2024, 1:28 am
       ---------------------------------------------------------
       From the New England Journal of Medicine (February 15,
       2024)--"Inhibition of CD40L with Frexalimab in Multiple
       Sclerosis":
  HTML https://bit.ly/49hB0M2
       The editorial contains this statement:
       [quote]Thus, progression is present in most, if not all,
       patients with multiple sclerosis, regardless of where they are
       in the disease continuum. [/quote]
       #Post#: 4317--------------------------------------------------
       (NEJM editorial) Silencing immune dialogue in MS
       By: agate Date: February 15, 2024, 1:38 am
       ---------------------------------------------------------
       An editorial about this study appears in the same issue of the
       New England Journal of Medicine (February 15, 2024)--"Silencing
       immune dialogue in multiple sclerosis":
  HTML https://bit.ly/49kGaHd
       *****************************************************